SCHEMBL81688

SCHEMBL81688

CC(C)(C)OO[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9718351 0.72 TSHR (0.50)
SCHEMBL28082245 0.69
SCHEMBL2587475 0.67
SCHEMBL27372650 0.67
SCHEMBL29421629 0.67
SCHEMBL754334 0.65 TDP1 (0.31)
SCHEMBL1670 0.65
SCHEMBL14861 0.64 TDP1 (1.00)
SCHEMBL28236221 0.64 TDP1 (1.00)
SCHEMBL11689973 0.62 TSHR (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1078 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103987747-B Unsaturated polyester resin composition and sealed motor SHOWA DENKO KABUSHIKI KAISHA (JP) 2015-12-09 CN claimed
US-3953416-A Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same FOLKERS KARL 1976-04-27 US claimed
US-20240218017-A1 PEPTIDE AMPHIPHILES WITH MODIFIED DEGRADING SEQUENCES AND METHODS OF USE THEREOF Endomimetics LLC 2024-07-04 US disclosed
US-20240199698-A1 PEPTIDE AMPHIPHILE COMPOSITIONS AND METHODS OF USE THEREOF Endomimetics LLC 2024-06-20 US disclosed
US-20240182574-A1 ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 THAT ARE PD-1 AGONISTS Georgiamune Inc. 2024-06-06 US disclosed
WO-2024119068-A2 S100A7 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR DISORDERS OHIO STATE INNOVATION FOUNDATION (US) 2024-06-06 WO disclosed
WO-2024102807-A2 IMMUNE CHECKPOINT INHIBITOR AND EXTRACELLULAR MATRIX COMPONENT BINDER COMBINATION THERAPY AND METHODS OF USE THEREOF NEXTCURE, INC. (US) 2024-05-16 WO disclosed
US-20240150397-A1 TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR Sanford Burnham Prebys Medical Discovery Institute 2024-05-09 US disclosed
US-20240148901-A1 COMPOSITIONS AND METHODS FOR PROPHYLAXIS OF HIV GEORGIA TECH RESEARCH CORPORATION (US) 2024-05-09 US disclosed
US-20240141305-A1 HSD17B13 VARIANTS AND USES THEREOF REGENERON PHARMACEUTICALS, INC. 2024-05-02 US disclosed
EP-3743447-B1 B7-H4 ANTIBODIES AND METHODS OF USE THEREOF NEXTCURE INC (US) 2024-03-27 EP disclosed
US-4855454-A CHEMICAL INTERMEDIATES; SWEETENERS PFIZER INC. (US) 1989-08-08 US disclosed
US-4665016-A QUANTITATIVE DETERMINATION OF ENDOPROTEASE BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1987-05-12 US disclosed
EP-0200404-A2 Solid phase process for synthesizing peptides ALPHA-1 BIOMEDICALS, INC. (US) 1986-11-05 EP disclosed
US-4238390-A Synthesis and biological activity of [D-Thr2, Δ3 Pro5 ]-enkephalinamide HOFFMANN-LA ROCHE INC. (US) 1980-12-09 US disclosed
US-4148788-A Synthesis of thymosin α1 HOFFMANN-LA ROCHE INC. (US) 1979-04-10 US disclosed
US-4116951-A [Asn2 ]-thymosin α1 and analogs thereof HOFFMANN-LA ROCHE INC. (US) 1978-09-26 US disclosed
US-4101464-A Process for preparing foamed solids using two or more azo compounds PENNWALT CORPORATION (US) 1978-07-18 US disclosed
US-4029615-A AZO COMPOUNDS PENNWALT CORPORATION (US) 1977-06-14 US disclosed
US-3993609-A ACID SENSITIVE AZO PROMOTERS PENNWALT CORPORATION (US) 1976-11-23 US disclosed